1c:{"metadata":[["$","title","0",{"children":"NIH VideoCast - SARS-CoV-2 Vaccines & Antibody Landscapes"}],["$","meta","1",{"name":"description","content":"COVID-19 Scientific Interest Group Lecture Series \n

\nIt can often feel like we can’t catch up to the newest SARS-CoV-2 variants. SARS-CoV-2 virus evolution is not predictable nor linear. Fortunately, our immune response to the virus and vaccine are not linear either. So instead of keeping up with the latest variant, can we broaden the immune response to cover areas where the virus may emerge? This talk will describe SARS-CoV-2 virus evolution and will discuss NIAID trials evaluating how to use different variant vaccines to broaden the antibody landscape to SARS-CoV-2.\n\n

\n\nFor more information go to https://www.niaid.nih.gov/research/covid-19-sig-lecture-series"}],["$","meta","2",{"name":"publisher","content":"National Institutes of Health"}],["$","meta","3",{"property":"og:title","content":"NIH VideoCast - SARS-CoV-2 Vaccines & Antibody Landscapes"}],["$","meta","4",{"property":"og:description","content":"COVID-19 Scientific Interest Group Lecture Series \n

\nIt can often feel like we can’t catch up to the newest SARS-CoV-2 variants. SARS-CoV-2 virus evolution is not predictable nor linear. Fortunately, our immune response to the virus and vaccine are not linear either. So instead of keeping up with the latest variant, can we broaden the immune response to cover areas where the virus may emerge? This talk will describe SARS-CoV-2 virus evolution and will discuss NIAID trials evaluating how to use different variant vaccines to broaden the antibody landscape to SARS-CoV-2.\n\n

\n\nFor more information go to https://www.niaid.nih.gov/research/covid-19-sig-lecture-series"}],["$","meta","5",{"property":"og:url","content":"https://uat.d1rkikwu4q8tg.amplifyapp.com/watch/c89c5cd6-d5db-11f0-9cf9-12c45c580ad9"}],["$","meta","6",{"property":"og:site_name","content":"NIH VideoCast"}],["$","meta","7",{"property":"og:image","content":"https://nihcit.rev.vbrick.com/api/v2/media/videos/thumbnails/9dc234d0-2a55-4eea-9110-082cdd3b3c51.jpg"}],["$","meta","8",{"property":"og:type","content":"website"}],["$","meta","9",{"name":"twitter:card","content":"summary_large_image"}],["$","meta","10",{"name":"twitter:title","content":"NIH VideoCast - SARS-CoV-2 Vaccines & Antibody Landscapes"}],["$","meta","11",{"name":"twitter:description","content":"COVID-19 Scientific Interest Group Lecture Series \n

\nIt can often feel like we can’t catch up to the newest SARS-CoV-2 variants. SARS-CoV-2 virus evolution is not predictable nor linear. Fortunately, our immune response to the virus and vaccine are not linear either. So instead of keeping up with the latest variant, can we broaden the immune response to cover areas where the virus may emerge? This talk will describe SARS-CoV-2 virus evolution and will discuss NIAID trials evaluating how to use different variant vaccines to broaden the antibody landscape to SARS-CoV-2.\n\n

\n\nFor more information go to https://www.niaid.nih.gov/research/covid-19-sig-lecture-series"}],["$","meta","12",{"name":"twitter:image","content":"https://nihcit.rev.vbrick.com/api/v2/media/videos/thumbnails/9dc234d0-2a55-4eea-9110-082cdd3b3c51.jpg"}],"$L22","$L23"],"error":null,"digest":"$undefined"}